Birdwatch Note
2024-10-30 18:10:06 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Les médicaments sont faits pour soigner et nécessitent des preuves scientifiques rigoureuses, pas les compléments. X.Azalbert est un homme d'affaires, pas un scientifique. Le Brésil est choisi pour ce brevet en raison d'un marché de compléments alimentaires en croissance. https://www.ameli.fr/assure/sante/medicaments/effets-secondaires-et-interactions-lies-aux-medicaments/complements-alimentaires https://www.researchandmarkets.com/reports/5789234/brazil-dietary-supplements-market-prospects https://www.insights10.com/report/brazil-nutritional-supplements-market-analysis/
Written by C0E4F4003B48B73EC21DE34E445D64CE2439361F5433B21081B240D1377E0C75
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1851667776303239306
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1851688040760328406
- noteId - 1851688040760328406
- participantId -
- noteAuthorParticipantId - C0E4F4003B48B73EC21DE34E445D64CE2439361F5433B21081B240D1377E0C75
- createdAtMillis - 1730311806274
- tweetId - 1851667776303239306
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Les médicaments sont faits pour soigner et nécessitent des preuves scientifiques rigoureuses, pas les compléments. X.Azalbert est un homme d'affaires, pas un scientifique. Le Brésil est choisi pour ce brevet en raison d'un marché de compléments alimentaires en croissance. https://www.ameli.fr/assure/sante/medicaments/effets-secondaires-et-interactions-lies-aux-medicaments/complements-alimentaires https://www.researchandmarkets.com/reports/5789234/brazil-dietary-supplements-market-prospects https://www.insights10.com/report/brazil-nutritional-supplements-market-analysis/
Note Ratings
| rated at | rated by | |
| 2024-10-30 15:31:46 -0500 | Rating Details | |
| 2024-10-30 13:43:25 -0500 | Rating Details | |
| 2024-10-30 15:52:45 -0500 | Rating Details | |
| 2024-10-30 13:11:23 -0500 | Rating Details | |
| 2024-10-30 15:39:15 -0500 | Rating Details |